Nanodropper Announces Growth in Partnerships and Availability

Nanodropper, a volume-reducing adaptor for eye drop bottles, announced major growth over the last 12 months, including an 832% increase in clinic partnerships, expanding to more than 840 clinic locations since June of 2021. Nanodropper has also more than doubled its team as it finalized research and development ahead of launching a new, more adaptive eye dropper product, which the company says will fit nearly 99% of all eye drop bottles on the market later this year. This announcement comes 1 year after the Nanodropper team attended its first in-person conference, the Optometry’s Meeting, which will take place again this weekend in Chicago.

The Nanodropper Adaptor, an adaptor for eye drop bottles designed to reduce the drop volume to just what the eye can absorb, is now available in 49 states, Washington D.C., Puerto Rico, and the Virgin Islands. The company has secured partnerships with health care institutions and companies like Johns Hopkins University, Seattle Children’s Hospital, Washington National Eye Center, Lumata Health, and, most recently, Vision Source, a family of more than 3,150 locally owned optometric practices across the country. In the first month of Nanodropper’s partnership with Vision Source, more than 70 Vision Source practices ordered the device, continuing to expand access points for patients. 

“Thinking back on the summer of 2021, right after we attended our first in-person conference as a Nanodropper team, and seeing how much traction Nanodropper has gained over the last year truly exemplifies the priority the health care industry is putting on value-based care,” Allisa Song, Co-founder and CEO of Nanodropper, said in a company news release. “We have a lot of milestones coming up, including the launch of our next Adaptor, which will address additional eye drop prescription needs, the publication of our clinical trials, and new partnerships with healthcare providers, all while continuing to prioritize the needs of the patient first.” 

Nanodropper is currently conducting or collaborating on seven clinical trials that are designed to further validate the effectiveness of the Nanodropper Adaptor microdrops compared to the standard drop size, addressing conditions such as glaucoma, ocular hypertension, and dilation. 

Nanodropper has not only seen growth in partnerships and locations, but has also expanded its team and office space. Nanodropper’s staff has more than doubled since June of 2021, now with eight employees. It also launched its only fulfillment center based in Rochester, Minnesota in 2021 after winning the Minnesota Cup startup competition as the first student-led company to ever win the award.

For more information, visit https://nanodropper.com.